美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA125513"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
25682-019-12 25682-019 HUMAN PRESCRIPTION DRUG STRENSIQ ASFOTASE ALFA SOLUTION SUBCUTANEOUS 20151023 N/A BLA BLA125513 Alexion Pharmaceuticals, Inc. ASFOTASE ALFA 80 mg/.8mL 12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01)
25682-016-12 25682-016 HUMAN PRESCRIPTION DRUG STRENSIQ ASFOTASE ALFA SOLUTION SUBCUTANEOUS 20151023 N/A BLA BLA125513 Alexion Pharmaceuticals, Inc. ASFOTASE ALFA 40 mg/mL 12 VIAL in 1 CARTON (25682-016-12) / 1 mL in 1 VIAL (25682-016-01)
25682-013-12 25682-013 HUMAN PRESCRIPTION DRUG STRENSIQ ASFOTASE ALFA SOLUTION SUBCUTANEOUS 20151023 N/A BLA BLA125513 Alexion Pharmaceuticals, Inc. ASFOTASE ALFA 28 mg/.7mL 12 VIAL in 1 CARTON (25682-013-12) / .7 mL in 1 VIAL (25682-013-01)
25682-010-12 25682-010 HUMAN PRESCRIPTION DRUG STRENSIQ ASFOTASE ALFA SOLUTION SUBCUTANEOUS 20151023 N/A BLA BLA125513 Alexion Pharmaceuticals, Inc. ASFOTASE ALFA 18 mg/.45mL 12 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase